BioElectronics Corporation, a prominent player in the medical technology sector, has announced the appointment of Dr. Sree Koneru to its Board of Directors, effective December 3, 2024. This strategic move aims to bolster the company’s leadership team as it continues to innovate in the field of neuromodulation and pain management solutions.
With this new addition, the Board of Directors now comprises three key members: Kelly Whelan, who serves as the President of BioElectronics, Richard Staelin, PhD, the Chairman, and the newly appointed Dr. Koneru. This restructuring is seen as a significant step forward in enhancing the company’s governance and operational capabilities.
Dr. Sree Koneru brings a wealth of experience to BioElectronics, particularly in the development of medical devices. Currently serving as the Director of Program Management at a contract manufacturing organization specializing in medical devices, Dr. Koneru has a robust background in product development. His previous role as Vice President of Product Development at BioElectronics has equipped him with valuable insights into the company’s operations and strategic objectives.
Dr. Koneru’s expertise spans across various critical areas, including the development of neuromodulation devices, prototype creation, clinical evaluation, and regulatory submissions. His track record includes securing FDA approvals and CE marking, which are essential for the commercialization of medical devices in the United States and Europe, respectively.
Dr. Koneru holds a PhD in Biomedical Engineering from SUNY Binghamton, further solidifying his qualifications in the medical technology field. His academic and professional background positions him as a vital asset to BioElectronics as the company seeks to expand its influence in the medical device market.
In a statement regarding his appointment, Kelly Whelan expressed enthusiasm for Dr. Koneru’s addition to the Board, stating, “We are honored to welcome Sree Koneru to the Board. Sree brings a rich depth of experience in medical device development. We welcome his insight as we execute our strategy.” This sentiment reflects the company’s commitment to leveraging Dr. Koneru’s expertise to navigate the complexities of the medical technology landscape.
Dr. Koneru also shared his excitement about joining the Board, emphasizing the alignment of BioElectronics’ mission with his personal passion for advancing neuromodulation technology. He stated, “I am honored to join the Board of Directors at BioElectronics, a company at the forefront of innovations in neuromodulation. The Company’s role in pioneering non-pharmacological solutions for pain management and other chronic disease states aligns with my passion for improving lives through advances in neuromodulation technology. I look forward to contributing to the success and transformative impact of the incredible technology manufactured and distributed by BioElectronics Corporation.”
Richard Staelin, PhD, the Chairman of the Board, highlighted the importance of Dr. Koneru’s role in guiding the company’s growth strategy. “As we continue to pursue our mission of focusing on R&D aimed at delivering non-pharmacological solutions for acute, chronic, and neuropathic pain, Sree is the ideal addition to our Board to help guide our growth as we scale efficiently while also reaching new markets,” he noted.
This appointment comes at a crucial time for BioElectronics as the company aims to enhance its research and development efforts and expand its product offerings. The integration of Dr. Koneru into the leadership team signals a strong commitment to innovation and excellence in the medical device sector.
As BioElectronics Corporation moves forward with its strategic initiatives, the addition of Dr. Koneru to the Board is expected to play a pivotal role in shaping the future of the company, particularly in the realms of product development and market expansion. The company’s focus on non-pharmacological solutions for pain management positions it well within a growing market that seeks alternatives to traditional pain relief methods.
With a renewed focus on innovation, BioElectronics is set to make significant strides in the medical technology field, and the expertise of its Board members, including Dr. Koneru, will be instrumental in driving the company’s vision and goals.
